Join
Live feed
·
INSIDERFilingvia Quantisnow
Aardvark Therapeutics Inc. logo

Former 10% Owner Cormorant Asset Management, Lp converted options into 800,189 shares and bought $3,000,000 worth of shares (187,500 units at $16.00) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AARD (Aardvark Therapeutics Inc.) and more on Quantisnow.

Former 10% Owner Cormorant Asset Management, Lp converted options into 800,189 shares and bought $3,000,000 worth of shares (187,500 units at $16.00) (SEC Form 4) | Quantisnow